Dee  Mangin, MBChB, DPH, FRNZCGP

Dee Mangin, MBChB, DPH, FRNZCGP

McMaster University

Professor Associate Chair and Director, Research David Braley & Nancy Gordon Chair in Family Medicine Professor and Director of Research, University of Otago, Christchurch

Expertise: Primary CarePolypharmacyMedication Safety and EffectivenessDrug Adverse Reactions

Dee Mangin is Professor of Family Medicine, David Braley Chair in Family Medicine and Research Director at the David Braley Primary Care Research Collaborative at McMaster University. 

Her broad interests are: rational prescribing and drug safety; innovative models of primary care delivery; effective incorporation of evidence into patient centred practice; and the influences of science, policy and commerce on the nature of care. Her current work focuses on both strengthening primary care, and matching the burden of care to the patient’s capacity to benefit. 

She has wide clinical research experience in primary care, including observational and interventional quantitative research methods and community RCTs of innovative models of care. Dr. Mangin has experience leading RCTs of clinical interventions in areas such as antidepressant use, community acquired pneumonia, antibiotics in urinary tract infections, the TAPER program of deprescribing research among older adults.

Before moving from New Zealand to Canada, Dee Mangin was the Director of the Primary Care Unit at the University of Otago, Christchurch, and Clinical Leader for Research Audit and Evaluation at the Pegasus Health Primary Healthcare Organisation.

She was a Ministerially appointed member of the New Zealand Pharmaceutical and Therapeutic Products Advisory Committee, PHARMAC. She is a Fellow of the Royal New Zealand College of General Practitioners, and in 2011 she received their Distinguished Service Medal. She was awarded both a Distinguished Paper at the North American Primary Care Research Group’s (NAPCRG) 2015 conference. She is the Director of MUSIC, the McMaster University Sentinel and Information Collaboration practice-based research network, and the Medical Director and cofounder of RxISK.org a website for consumer information and reporting of drug adverse reactions, as well as Chief Medical Officer for TaperMD, a clinical pathway for reducing polypharmacy. 


Title

Cited By

Year

Feasibility study of a systematic approach for discontinuation of multiple medications in older adults: addressing polypharmacy

602

2010

A meta-analysis of hospital in the home

179

2012

Randomised controlled trial of intravenous antibiotic treatment for cellulitis at home compared with hospital

177

2005

Tratado de Medicina de Família e Comunidade-: Princípios, Formação e Prática

155

2018

Preventive health care in elderly people needs rethinking

154

2007

Beyond diagnosis: rising to the multimorbidity challenge

148

2012

The Quality and Outcomes Framework: what have you done to yourselves?

107

2007

Response to antibiotics of women with symptoms of urinary tract infection but negative dipstick urine test results: double blind randomised controlled trial July; 331(7509):143 …

91

2005

Challenges and enablers of deprescribing: a general practitioner perspective

88

2016

Direct to consumer advertising

67

2004

Clinical care and health disparities

58

2012

International group for reducing inappropriate medication use & polypharmacy (IGRIMUP): position statement and 10 recommendations for action

54

2018

Making patient values visible in healthcare: a systematic review of tools to assess patient treatment priorities and preferences in the context of multimorbidity

54

2016

The Quality and Outcomes Framework: QOF-transforming general practice

48

2018

Home management of mild to moderately severe community acquired pneumonia: a randomized controlled trial

47

2005

Enduring sexual dysfunction after treatment with antidepressants, 5 α-reductase inhibitors and isotretinoin: 300 cases

40

2018

Antibiotic resistance in uncomplicated urinary tract infection: problems with interpreting cumulative resistance rates from local community laboratories

39

2002

Prevalence of complementary and alternative medicine use in Christchurch, New Zealand: children attending general practice versus paediatric outpatients

38

2007

Do clinical practice education groups change GP prescribing?

38

2003

One hundred and twenty cases of enduring sexual dysfunction following treatment

36

2014

New research collaboration enhances primary care

The collaborate will bring together researchers, clinicians, educators and partners to work on issues that will address the diverse needs of our community, including bringing paramedics into subsidized housing, prison health research, indigenous teaching through art, bringing trained volunteers into the homes of older adults, studying how to reduce the number of unnecessary medications a patient takes, and more.
30-Sep-2020 11:35:54 AM EDT

[On quitting antidepressants] "It’s tremendously frustrating when patients describe a different experience than physicians expect, and don’t feel they’re being heard.”

- https://www.nytimes.com/2019/03/05/health/depression-withdrawal-drugs.html

“Our whole medical system is geared to starting things, but completely invisible in the prescribing system is a setup for stopping things. For many drugs, the original reasons for taking them become lost in the mist of time.”

- https://www.consumerreports.org/prescription-drugs/should-you-still-be-taking-that-medicine/

Available for logged-in users onlyLogin HereorRegister
close
0.06969